CN113812378B - 一种食蟹猴肥胖症模型的建立方法及其应用 - Google Patents
一种食蟹猴肥胖症模型的建立方法及其应用 Download PDFInfo
- Publication number
- CN113812378B CN113812378B CN202111150442.0A CN202111150442A CN113812378B CN 113812378 B CN113812378 B CN 113812378B CN 202111150442 A CN202111150442 A CN 202111150442A CN 113812378 B CN113812378 B CN 113812378B
- Authority
- CN
- China
- Prior art keywords
- feeding
- sugar
- obesity
- time
- cynomolgus monkey
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000008589 Obesity Diseases 0.000 title claims abstract description 80
- 235000020824 obesity Nutrition 0.000 title claims abstract description 80
- 241000282567 Macaca fascicularis Species 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 39
- 235000000346 sugar Nutrition 0.000 claims abstract description 64
- 235000015895 biscuits Nutrition 0.000 claims abstract description 19
- 230000000295 complement effect Effects 0.000 claims abstract description 14
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 241000287828 Gallus gallus Species 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000012216 screening Methods 0.000 claims abstract description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 22
- 239000004615 ingredient Substances 0.000 claims description 12
- 235000012000 cholesterol Nutrition 0.000 claims description 11
- 235000021552 granulated sugar Nutrition 0.000 claims description 11
- 239000005715 Fructose Substances 0.000 claims description 8
- 229930091371 Fructose Natural products 0.000 claims description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 7
- 235000016709 nutrition Nutrition 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 235000005911 diet Nutrition 0.000 claims description 5
- 230000037213 diet Effects 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 4
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 4
- 244000060011 Cocos nucifera Species 0.000 claims description 4
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 4
- 235000019733 Fish meal Nutrition 0.000 claims description 4
- 235000019764 Soybean Meal Nutrition 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 4
- 239000001099 ammonium carbonate Substances 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 239000004467 fishmeal Substances 0.000 claims description 4
- 235000013312 flour Nutrition 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000004455 soybean meal Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 229940126585 therapeutic drug Drugs 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 2
- 235000013599 spices Nutrition 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 abstract description 14
- 238000010171 animal model Methods 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 241000725303 Human immunodeficiency virus Species 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 208000031873 Animal Disease Models Diseases 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- 238000012827 research and development Methods 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 description 12
- 206010033307 Overweight Diseases 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 8
- 241000283984 Rodentia Species 0.000 description 7
- 235000009200 high fat diet Nutrition 0.000 description 7
- -1 Carbohydrate compound Chemical class 0.000 description 6
- 241000282412 Homo Species 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 6
- 238000011160 research Methods 0.000 description 5
- 206010067125 Liver injury Diseases 0.000 description 4
- 241000282560 Macaca mulatta Species 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000019137 high fructose diet Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 208000004611 Abdominal Obesity Diseases 0.000 description 2
- 206010065941 Central obesity Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 238000010362 genome editing Methods 0.000 description 2
- 231100000234 hepatic damage Toxicity 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000008818 liver damage Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000011623 obesity animal model Methods 0.000 description 2
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 2
- 229960001243 orlistat Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011809 primate model Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010014486 Elevated triglycerides Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 206010057178 Osteoarthropathies Diseases 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000007707 calorimetry Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 238000001861 endoscopic biopsy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 231100000502 fertility decrease Toxicity 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 208000001797 obstructive sleep apnea Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 235000000891 standard diet Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035924 thermogenesis Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 230000036266 weeks of gestation Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/22—Animal feeding-stuffs from material of animal origin from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/22—Compounds of alkali metals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Health & Medical Sciences (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Environmental Sciences (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Birds (AREA)
- Fodder In General (AREA)
Abstract
Description
项目 | 每100g |
能量 | ≥1590kj |
蛋白质 | 15-20g |
脂肪 | 5-7g |
胆固醇 | 0mg |
碳水化合物 | 70-80g |
钠 | 260-300mg |
项目 | 每100g |
能量 | ≥380kj |
蛋白质 | 0.5-1.5g |
脂肪 | 0g |
胆固醇 | 0mg |
碳水化合物 | 90-110g |
钠 | 15-25mg |
项目 | 每100g |
能量 | ≥1890kj |
蛋白质 | 3-8g |
脂肪 | 15-25g |
胆固醇 | 0mg |
反式脂肪酸 | 0.5-1.5mg |
碳水化合物 | 50-70g |
钠 | 250-270mg |
项目 | 每100g |
能量 | 1597kj |
蛋白质 | 18.6g |
脂肪 | 5.8g |
胆固醇 | 0mg |
碳水化合物 | 74.4g |
钠 | 281mg |
项目 | 每100g |
能量 | 1898kj |
蛋白质 | 5.3g |
脂肪 | 20g |
胆固醇 | 0mg |
反式脂肪酸 | 0.9mg |
碳水化合物 | 61.0g |
钠 | 264mg |
项目 | 每100g |
能量 | 1539kj |
蛋白质 | 18.5g |
脂肪 | 5.8g |
胆固醇 | 0mg |
碳水化合物 | 59.4g |
钠 | 279mg |
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111150442.0A CN113812378B (zh) | 2021-09-29 | 2021-09-29 | 一种食蟹猴肥胖症模型的建立方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111150442.0A CN113812378B (zh) | 2021-09-29 | 2021-09-29 | 一种食蟹猴肥胖症模型的建立方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113812378A CN113812378A (zh) | 2021-12-21 |
CN113812378B true CN113812378B (zh) | 2023-02-03 |
Family
ID=78921666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111150442.0A Active CN113812378B (zh) | 2021-09-29 | 2021-09-29 | 一种食蟹猴肥胖症模型的建立方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113812378B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102792919A (zh) * | 2012-08-08 | 2012-11-28 | 上海交通大学 | 悉生动物肥胖模型的构建方法及其应用 |
CN103416608A (zh) * | 2012-12-28 | 2013-12-04 | 广西南宁灵康赛诺科生物科技有限公司 | 灵长类实验型高脂饲料及其制备方法 |
CN108024977A (zh) * | 2015-09-15 | 2018-05-11 | 詹森药业有限公司 | 用于治疗肥胖症和肥胖症相关疾病的包含卡格列净和芬特明的协同治疗 |
WO2018104499A1 (en) * | 2016-12-08 | 2018-06-14 | Juntti Berggren Lisa | Methods for treating and limiting development of obesity and fatty liver disorders |
CN111328920A (zh) * | 2020-03-10 | 2020-06-26 | 昆明科灵生物科技有限公司 | 一种构建非人灵长类动物非酒精性脂肪性肝炎模型用饲料及其使用方法 |
CN112425561A (zh) * | 2020-10-27 | 2021-03-02 | 广东蓝岛生物技术有限公司 | 一种糖尿病灵长类动物模型构建方法 |
-
2021
- 2021-09-29 CN CN202111150442.0A patent/CN113812378B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102792919A (zh) * | 2012-08-08 | 2012-11-28 | 上海交通大学 | 悉生动物肥胖模型的构建方法及其应用 |
CN103416608A (zh) * | 2012-12-28 | 2013-12-04 | 广西南宁灵康赛诺科生物科技有限公司 | 灵长类实验型高脂饲料及其制备方法 |
CN108024977A (zh) * | 2015-09-15 | 2018-05-11 | 詹森药业有限公司 | 用于治疗肥胖症和肥胖症相关疾病的包含卡格列净和芬特明的协同治疗 |
WO2018104499A1 (en) * | 2016-12-08 | 2018-06-14 | Juntti Berggren Lisa | Methods for treating and limiting development of obesity and fatty liver disorders |
CN111328920A (zh) * | 2020-03-10 | 2020-06-26 | 昆明科灵生物科技有限公司 | 一种构建非人灵长类动物非酒精性脂肪性肝炎模型用饲料及其使用方法 |
CN112425561A (zh) * | 2020-10-27 | 2021-03-02 | 广东蓝岛生物技术有限公司 | 一种糖尿病灵长类动物模型构建方法 |
Non-Patent Citations (1)
Title |
---|
高能量膳食诱导食蟹猴2型糖尿病模型的研究;张艳春 等;《动物医学进展》;20120831;第33卷(第8期);第47-52页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113812378A (zh) | 2021-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Banta et al. | Sites of organic acid production and patterns of digesta movement in the gastrointestinal tract of dogs | |
Kral | Vagotomy for treatment of severe obesity | |
CN104642735B (zh) | 一种饲料用复合糖制剂及含其饲料和应用 | |
CN114258988A (zh) | 一种改善母猪妊娠期便秘的纤维饲料及其制备方法 | |
CN113812378B (zh) | 一种食蟹猴肥胖症模型的建立方法及其应用 | |
JP2022056858A (ja) | エルゴチオネインを含む食品又は飼料 | |
CN105941906A (zh) | 妊娠前期初产母猪的饲料及应用 | |
CN105028978A (zh) | 一种改善草鱼肠道功能的饲料添加剂及其应用 | |
Leenhouwers et al. | Differences in late prenatal development as an explanation for genetic differences in piglet survival | |
CN112006166A (zh) | 提高仔猪成活率和生长速度的丝氨酸饲料添加剂及其应用 | |
CN1655810A (zh) | 高尿酸血症治疗或预防用组合物 | |
CN106070009A (zh) | 一种sd大鼠生产方法 | |
CN105360688A (zh) | 一种含铬肉鸭饲料 | |
HARNED et al. | Evidence of hyperfunction of the anterior pituitary in a strain of rats | |
JPWO2008111651A1 (ja) | メタボリックシンドローム改善又は予防剤、並びにこれを含有する飲料、食品及び飼料 | |
CN109221715A (zh) | 一种用于天府肉猪后备母猪围产期的配合饲料及制备方法 | |
Segal, I. & Hunt | The irritable bowel syndrome in the urban South African Negro | |
JP2020092691A (ja) | ケトン食用栄養組成物 | |
CN113711994A (zh) | 一种食蟹猴2型糖尿病模型的建立方法及其应用 | |
Semprini et al. | Effect of monosodium glutamate on fetus and newborn mouse | |
JP4893914B2 (ja) | 経管栄養組成物 | |
Pond et al. | Maternal tissue repartitioning in pregnant primiparous swine in response to restriction of calories or feed | |
CN106306452A (zh) | 一种利于预防母猪流产的保健饲料添加剂及其制备方法 | |
CN113796354A (zh) | 食蟹猴高甘油三酯血症模型的建立方法及其应用 | |
JP2003246728A (ja) | クロソ蛋白質発現量の減少により引きおこされる疾患の治療または予防剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240229 Address after: Room 1, 3rd Floor, Building 27, Phase 1.2, Optics Valley International Biopharmaceutical Enterprise Accelerator, No. 388 Gaoxin Second Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430000 Patentee after: Hubei tianqin Biotechnology Research Institute Co.,Ltd. Country or region after: China Patentee after: Hubei Tianqin Xinsheng Biotechnology Co.,Ltd. Address before: 430206 room 1, floor 3, building 27, phase 1.2, Optical Valley International Biomedical enterprise accelerator, No. 388, Gaoxin Second Road, Donghu New Technology Development Zone, Wuhan, Hubei Province Patentee before: Hubei tianqin Biotechnology Research Institute Co.,Ltd. Country or region before: China |